Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/22/1995 | EP0643719A1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor |
03/22/1995 | EP0643582A1 Method for producing a supernatant of activated thrombocytes |
03/22/1995 | EP0440763B1 t-PA MUTANT GK1L |
03/21/1995 | US5399680 Rice chitinase promoter |
03/21/1995 | US5399665 Biodegradable polymers for cell transplantation |
03/21/1995 | US5399493 Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
03/21/1995 | US5399346 Gene therapy |
03/16/1995 | WO1995007463A1 Uses of green fluorescent protein |
03/16/1995 | WO1995007462A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases |
03/16/1995 | WO1995007358A1 Efficient gene transfer into primary lymphocytes |
03/16/1995 | WO1995007353A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
03/16/1995 | WO1995007348A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
03/16/1995 | WO1995007344A1 Gas permeable bioreactor and method of use |
03/16/1995 | WO1995007301A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
03/16/1995 | WO1995007105A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
03/16/1995 | WO1995003328A3 Melanoma-inhibiting protein |
03/16/1995 | WO1995000643A3 Human cell adhesion protein aamp-1 and uses thereof |
03/16/1995 | DE4330960A1 Transgenic plant producing high grade amylose contg. starch |
03/16/1995 | CA2171313A1 Combination of dna sequences which enable the formation of modified starch in plant cells and plants, processes for the production of these plants and the modified starch obtainable therefrom |
03/16/1995 | CA2171211A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response |
03/16/1995 | CA2171193A1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
03/16/1995 | CA2171112A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
03/16/1995 | CA2170623A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases |
03/16/1995 | CA2169298A1 Uses of green fluorescent protein |
03/16/1995 | CA2168202A1 Efficient gene transfer into primary lymphocytes |
03/15/1995 | EP0643077A1 Monoclonal antibody against B70 molecule |
03/15/1995 | EP0642761A1 Method of quantitative determination of bone salt with ct equipment |
03/15/1995 | EP0642591A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
03/15/1995 | EP0642589A1 Method and reagent for inhibiting viral replication |
03/15/1995 | EP0642586A1 CULTURED $i(TAXUS) TISSUES AS A SOURCE OF TAXOL, RELATED TAXANES AND OTHER NOVEL ANTI-TUMOR/ANTI-VIRAL COMPOUNDS |
03/15/1995 | EP0642580A1 Hepatocyte growth factor variants |
03/15/1995 | EP0642579A1 Improved methods for the preparation of endotoxin-binding proteins |
03/15/1995 | EP0642577A1 Antibodies with specificity for multiple adhesion molecules |
03/15/1995 | EP0642356A1 Antibodies to p-selectin and their uses |
03/15/1995 | EP0642326A1 Non-fibrogenic, alginate-coated transplants, process of manufacture and method of use thereof |
03/15/1995 | EP0642301A1 Pharmaceutically acceptable fixed-dried human blood platelets |
03/15/1995 | EP0422209B1 Implants for large volumes of cells on polymeric matrices |
03/14/1995 | US5397706 Serum-free basal and culture medium for hematopoietic and leukemia cells |
03/14/1995 | US5397703 Method for generation of antibodies to cell surface molecules |
03/09/1995 | WO1995006754A1 Methods for screening antiestrogen compounds |
03/09/1995 | WO1995006748A1 Monoclonal antibody that induces apoptosis |
03/09/1995 | WO1995006747A1 Monoclonal antibody that recognizes interstitial cell surface antigen |
03/09/1995 | WO1995006744A2 Methods of suppressing immune response by gene therapy |
03/09/1995 | WO1995006741A1 Method of production of transgenic plants wholly transformed into to generation, from meristems |
03/09/1995 | WO1995006735A2 Nucleotide sequences for novel protein tyrosine phosphatases |
03/09/1995 | WO1995006734A1 Cloning of a member of the serine-threonine-kinase family |
03/09/1995 | WO1995006723A1 Method of marking eukaryotic cells by the use of a cell surface receptor as a marker |
03/09/1995 | WO1995006718A2 Methods of suppressing autoimmune response |
03/09/1995 | WO1995006717A2 Methods of suppressing graft rejection |
03/09/1995 | WO1995006716A1 Rat pluripotent embryonic stem cells and method of obtaining and using same |
03/09/1995 | WO1995006666A1 Anti-gp39 antibodies and uses therefor |
03/09/1995 | WO1995006664A1 Dna encoding prostaglandin receptor ep2 |
03/09/1995 | WO1995006481A1 Methods for inducing antigen-specific t cell tolerance |
03/09/1995 | WO1995006415A1 Senescent cell-derived inhibitors of dna synthesis |
03/09/1995 | WO1995006409A1 Genetically modified human hematopoietic stem cells and their progeny |
03/09/1995 | WO1995002056A3 Lettuce infectious yellows virus genes |
03/09/1995 | WO1995001439A3 Plants having modified response to ethylene |
03/09/1995 | DE4430637A1 Neue Brassica oleracea Pflanzen New Brassica oleracea plants |
03/09/1995 | CA2565423A1 Enhanced expression in plants using non-translated leader sequences |
03/09/1995 | CA2170980A1 Genetically modified human hematopoietic stem cells and their progeny |
03/09/1995 | CA2170393A1 Cloning of a member of the serine-threonine-kinase family |
03/09/1995 | CA2169951A1 Monoclonal antibody that recognizes interstitial cell surface antigen |
03/09/1995 | CA2169950A1 Monoclonal antibody that induces apoptosis |
03/09/1995 | CA2169466A1 Methods for screening antiestrogen compounds |
03/09/1995 | CA2158934A1 Methods of suppressing immune response by gene therapy |
03/09/1995 | CA2158933A1 Methods of suppressing graft rejection |
03/09/1995 | CA2158932A1 Methods of suppressing autoimmune response |
03/09/1995 | CA2118990A1 Catalytic antibodies hydrolyzing acylated carbohydrates with a regio-and stereoselective manner |
03/08/1995 | EP0642022A2 Stabilizing medium for blood |
03/08/1995 | EP0641801A2 Catalytic antibodies hydrolyzing acylated carbohydrates with a region- and stereoselective manner |
03/08/1995 | EP0641385A1 Development of dna probes and immunological reagents of human tumor associated antigens |
03/08/1995 | EP0641383A1 Cellular aggregate stabilized culture and process for the development of embryos from a proembryogenic strain for use in vine regeneration techniques |
03/08/1995 | EP0641223A1 Biotherapeutic cell-coated microspheres |
03/08/1995 | EP0641220A1 Methods and agents for modulating immune response, and uses thereof |
03/08/1995 | EP0641183A1 Coated transplant and method for making same |
03/08/1995 | EP0402449B1 Apparatus and process for culturing animal cells |
03/08/1995 | CN1099801A Peptides |
03/08/1995 | CN1099800A Fungus resistant plants |
03/08/1995 | CN1099797A Method for preparing powder type culture-medium of animal cell |
03/07/1995 | CA1334652C Histamine release inhibitory factor and preparations thereof |
03/03/1995 | CA2131433A1 Mice deficient in neurotrophin receptors |
03/02/1995 | WO1995006255A1 Hydrazine derivatized cells |
03/02/1995 | WO1995006250A1 Molecular clones producing recombinant dna antigens of the hards virus |
03/02/1995 | WO1995006247A1 Natural killer cell-specific antigen and antibodies that identify the same |
03/02/1995 | WO1995006128A2 Fertile, transgenic maize plants and methods for their production |
03/02/1995 | WO1995006124A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
03/02/1995 | WO1995006120A1 Recombinant cells from the monocyte-macrophage cell line for gene therapy |
03/02/1995 | WO1995006119A1 Recombinant humanized anti-human immunodeficiency virus antibody |
03/02/1995 | WO1995006117A1 Human 5-ht2 receptor |
03/02/1995 | WO1995006112A1 In vitro growth of neutrophil and megakaryocyte precursors in serum-free media |
03/02/1995 | WO1995006065A1 Cytokines that bind the cell surface receptor hek |
03/02/1995 | WO1995005853A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides |
03/02/1995 | WO1995005843A1 Method for producing a highly enriched population of hematopoietic stem cells |
03/02/1995 | WO1995005750A1 Cell death regulator |
03/02/1995 | WO1995003414A3 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
03/02/1995 | DE4425481A1 Melanoma-inhibiting protein |
03/02/1995 | DE4321944A1 Method for the diagnosis and analysis of colon carcinomas |
03/02/1995 | CA2623540A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
03/02/1995 | CA2170357A1 Method for producing a highly enriched population of hematopoietic stem cells |
03/02/1995 | CA2170352A1 Natural killer cell-specific antigen and antibodies that identify the same |